Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Extreme Lateral Interbody Fusion (XLIF) Surgery report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Extreme Lateral Interbody Fusion (XLIF) Surgery market is projected to reach US$ 1342.7 million in 2033, increasing from US$ 1000 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2033. Demand from Spinal Surgery Centers and Hospitals are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Extreme Lateral Interbody Fusion (XLIF) Surgery industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Extreme Lateral Interbody Fusion (XLIF) Surgery key companies include Medtronic Plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG and Alphatec Holdings Inc., etc. Medtronic Plc, Johnson & Johnson, Stryker Corporation are top 3 players and held % share in total in 2022.
Extreme Lateral Interbody Fusion (XLIF) Surgery can be divided into XLIF Interbody Fusion Systems and XLIF Interbody Cages, etc. XLIF Interbody Fusion Systems is the mainstream product in the market, accounting for % share globally in 2022.
Extreme Lateral Interbody Fusion (XLIF) Surgery is widely used in various fields, such as Spinal Surgery Centers, Hospitals and Others,, etc. Spinal Surgery Centers provides greatest supports to the Extreme Lateral Interbody Fusion (XLIF) Surgery industry development. In 2022, global % share of Extreme Lateral Interbody Fusion (XLIF) Surgery went into Spinal Surgery Centers filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Extreme Lateral Interbody Fusion (XLIF) Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Medtronic Plc
Johnson & Johnson
Stryker Corporation
Zimmer Biomet Holdings Inc.
NuVasive Inc.
Globus Medical Inc.
DePuy Synthes
B. Braun Melsungen AG
Alphatec Holdings Inc.
RTI Surgical Holdings Inc.
K2M Group Holdings Inc.
Orthofix Medical Inc.
Aesculap Implant Systems
SpineWave Inc.
MicroPort Scientific Corporation
Life Spine Inc.
Captiva Spine Inc.
CoreLink Surgical LLC
CTL Medical Corporation
Providence Medical Technology Inc.
Safe Orthopaedics
Spinal Elements Holdings Inc.
Spineology Inc.
Wenzel Spine Inc.
Xenco Medical.
Segment by Type
XLIF Interbody Fusion Systems
XLIF Interbody Cages
Spinal Surgery Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Extreme Lateral Interbody Fusion (XLIF) Surgery market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Extreme Lateral Interbody Fusion (XLIF) Surgery introduction, etc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Extreme Lateral Interbody Fusion (XLIF) Surgery market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
North America, Europe and Asia Pacific are the key regions for Extreme Lateral Interbody Fusion (XLIF) Surgery industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Extreme Lateral Interbody Fusion (XLIF) Surgery key companies include Medtronic Plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG and Alphatec Holdings Inc., etc. Medtronic Plc, Johnson & Johnson, Stryker Corporation are top 3 players and held % share in total in 2022.
Extreme Lateral Interbody Fusion (XLIF) Surgery can be divided into XLIF Interbody Fusion Systems and XLIF Interbody Cages, etc. XLIF Interbody Fusion Systems is the mainstream product in the market, accounting for % share globally in 2022.
Extreme Lateral Interbody Fusion (XLIF) Surgery is widely used in various fields, such as Spinal Surgery Centers, Hospitals and Others,, etc. Spinal Surgery Centers provides greatest supports to the Extreme Lateral Interbody Fusion (XLIF) Surgery industry development. In 2022, global % share of Extreme Lateral Interbody Fusion (XLIF) Surgery went into Spinal Surgery Centers filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Extreme Lateral Interbody Fusion (XLIF) Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Medtronic Plc
Johnson & Johnson
Stryker Corporation
Zimmer Biomet Holdings Inc.
NuVasive Inc.
Globus Medical Inc.
DePuy Synthes
B. Braun Melsungen AG
Alphatec Holdings Inc.
RTI Surgical Holdings Inc.
K2M Group Holdings Inc.
Orthofix Medical Inc.
Aesculap Implant Systems
SpineWave Inc.
MicroPort Scientific Corporation
Life Spine Inc.
Captiva Spine Inc.
CoreLink Surgical LLC
CTL Medical Corporation
Providence Medical Technology Inc.
Safe Orthopaedics
Spinal Elements Holdings Inc.
Spineology Inc.
Wenzel Spine Inc.
Xenco Medical.
Segment by Type
XLIF Interbody Fusion Systems
XLIF Interbody Cages
Segment by Application
Spinal Surgery Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Extreme Lateral Interbody Fusion (XLIF) Surgery market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Extreme Lateral Interbody Fusion (XLIF) Surgery introduction, etc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Extreme Lateral Interbody Fusion (XLIF) Surgery market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices